Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Colorcon
Queensland Health
Cipla
Medtronic
Baxter
QuintilesIMS
Moodys

Generated: June 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,114,909

« Back to Dashboard

Which drugs does patent 8,114,909 protect, and when does it expire?

Patent 8,114,909 protects HORIZANT and is included in one NDA.

This patent has twenty-two patent family members in fifteen countries.
Summary for Patent: 8,114,909
Title:Treating or preventing restless legs syndrome using prodrugs of GABA analogs
Abstract: Disclosed herein are methods of using prodrugs of gamma aminobutyric acid (GABA) analogs and pharmaceutical compositions thereof to treat or prevent restless legs syndrome in humans, and pharmaceutical compositions of prodrugs of GABA analogs useful in treating or preventing restless legs syndrome.
Inventor(s): Barrett; Ronald W. (Saratoga, CA), Canafax; Daniel M. (Half Moon Bay, CA)
Assignee: XenoPort, Inc. (Santa Clara, CA)
Application Number:10/969,196
Patent Claim Types:
see list of patent claims
Use; Dosage form;

Drugs Protected by US Patent 8,114,909

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Arbor Pharms Llc HORIZANT gabapentin enacarbil TABLET, EXTENDED RELEASE;ORAL 022399-002 Dec 13, 2011 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial TREATMENT OF MODERATE-TO-SEVERE PRIMARY RESTLESS LEG SYNDROME IN ADULTS ➤ Try a Free Trial
Arbor Pharms Llc HORIZANT gabapentin enacarbil TABLET, EXTENDED RELEASE;ORAL 022399-001 Apr 6, 2011 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial TREATMENT OF MODERATE-TO-SEVERE PRIMARY RESTLESS LEG SYNDROME IN ADULTS ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 8,114,909

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2004274002 ➤ Try a Free Trial
Brazil PI0414481 ➤ Try a Free Trial
Canada 2538802 ➤ Try a Free Trial
China 1871021 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Farmers Insurance
Daiichi Sankyo
Federal Trade Commission
Cantor Fitzgerald
Chubb
AstraZeneca
Cipla
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.